secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001829126-25-001253
Event type: other_material
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 5.02, 3.01, 3.03, 5.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel changes control; new majority owner holds 70% and appoints new CEO and CFO
--------------------------------------------------------------------------------

- Datuk Dr. Doris Wong Sing Ee bought 1M Series C and 1.745M Series D shares from ex-interim CEO David Lazar for $6.3M, gaining 70% ownership.
- Preferred shares converted into 194.63M common shares, making Wong the controlling shareholder.
- David Lazar resigned as interim CEO; Datuk Dr. Doris Wong Sing Ee appointed CEO and director; Kiu Cu Seng appointed CFO, executive director, secretary.
- Five directors resigned, including Samuel Barker, Paul McBarron, Spiro Rombotis; new independent director Chong Kwang Fock appointed.
- Nasdaq compliance regained for equity rule; company subject to one-year Mandatory Panel Monitor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/0001829126-25-001253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/cyclacel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-001253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer